Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

McGill University

$366,960.00

Ethics, Efficiency and Patient Burden in Drug Development

EF 2015-16

Résumé
Most new drugs entered into clinical development never show adequate safety and efficacy. As a result, many patients are harmed, resources are wasted, and major medical advances are delayed. This grant will follow up on previous work suggesting that researchers can be very efficient at identifying a drug's medical promise. However, they can also be very slow to abandon hypotheses that are wrong. We will examine when and why inefficiencies occur in drug development, and how patients can be protected from risks when they enrol in trials of experimental drugs.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
345282
Name
Kimmelman Jonathan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Ethics, Efficiency and Patient Burden in Drug Development
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$366,960
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Clinical Trials; Drug Development; Knowledge Translation; Medical Evidence; Research Ethics; Research Integrity; Risk; Systematic Review; Translational Research; Validity
Abstract
Most new drugs entered into clinical development never show adequate safety and efficacy. As a result, many patients are harmed, resources are wasted, and major medical advances are delayed. This grant will follow up on previous work suggesting that researchers can be very efficient at identifying a drug's medical promise. However, they can also be very slow to abandon hypotheses that are wrong. We will examine when and why inefficiencies occur in drug development, and how patients can be protected from risks when they enrol in trials of experimental drugs.
Competitiondate
201603
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Kimmelman, Jonathan
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $366,960~ $0~